Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle M Boisen

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Molecular and Cellular Endocrinology|August 16, 2015
Treating gynecologic malignancies with selective estrogen receptor downregulators (SERDs): promise and challengesMichelle M Boisen, Courtney L Andersen, Sreeja Sreekumar, et al.
Gynecologic Oncology|June 23, 2018
Unplanned postoperative intensive care unit admission for ovarian cancer cytoreduction is associated with significant decrease in overall survivalMalcolm S Ross, Mary E Burriss, Daniel G Winger, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 7, 2016
Second-line Intraperitoneal Platinum-based Therapy Leads to an Increase in Second-line Progression-free Survival for Epithelial Ovarian CancerMichelle M Boisen, Jamie L Lesnock, Scott D Richard, et al.
Journal of Gastrointestinal Oncology|March 5, 2016
Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancers: is there a role?Michelle M Boisen, Scott D Richard, Matthew P Holtzman, et al.
American Journal of Clinical Oncology|April 23, 2025
The Role of Adjuvant Chemotherapy in Endometrial Cancer Following Preoperative Neoadjuvant Chemoradiation TherapyMargaret R Flanigan, Michelle Ertel, John A Vargo, et al.
Hormones & Cancer|October 11, 2018
The Evolution of Estrogen Receptor Signaling in the Progression of Endometriosis to Endometriosis-Associated Ovarian CancerCourtney L Andersen, Michelle M Boisen, Matthew J Sikora, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 10, 2016
Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysisHeidi S Donovan, Teresa L Hagan, Grace B Campbell, et al.
JCO Oncology Practice|September 10, 2019
Integrating Family Caregiver Support Into a Gynecologic Oncology Practice: An ASCO Quality Training Program ProjectGrace B Campbell, Michelle M Boisen, Lauren C Hand, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 31, 2016
Surgical Outcomes of Patients Undergoing Extrafascial Hysterectomy After Neoadjuvant Radiotherapy With or Without Chemotherapy for Locally Advanced Endometrial Cancer Clinically Extending to the Cervix or ParametriaMichelle M Boisen, J Austin Vargo, Sushi Beriwal, et al.
Journal of Minimally Invasive Gynecology|May 20, 2022
Same-day Hospital Discharge after Minimally Invasive Hysterectomy in a Gynecologic Oncology Practice: Feasibility, Safety, Predictors of Admission, and Adverse OutcomesAlyssa M Wield, Michael G Cohen, Coralee T Toal, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Molecular and Cellular Endocrinology|August 16, 2015
Treating gynecologic malignancies with selective estrogen receptor downregulators (SERDs): promise and challengesMichelle M Boisen, Courtney L Andersen, Sreeja Sreekumar, et al.
Gynecologic Oncology|June 23, 2018
Unplanned postoperative intensive care unit admission for ovarian cancer cytoreduction is associated with significant decrease in overall survivalMalcolm S Ross, Mary E Burriss, Daniel G Winger, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 7, 2016
Second-line Intraperitoneal Platinum-based Therapy Leads to an Increase in Second-line Progression-free Survival for Epithelial Ovarian CancerMichelle M Boisen, Jamie L Lesnock, Scott D Richard, et al.
Journal of Gastrointestinal Oncology|March 5, 2016
Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancers: is there a role?Michelle M Boisen, Scott D Richard, Matthew P Holtzman, et al.
American Journal of Clinical Oncology|April 23, 2025
The Role of Adjuvant Chemotherapy in Endometrial Cancer Following Preoperative Neoadjuvant Chemoradiation TherapyMargaret R Flanigan, Michelle Ertel, John A Vargo, et al.
Hormones & Cancer|October 11, 2018
The Evolution of Estrogen Receptor Signaling in the Progression of Endometriosis to Endometriosis-Associated Ovarian CancerCourtney L Andersen, Michelle M Boisen, Matthew J Sikora, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 10, 2016
Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysisHeidi S Donovan, Teresa L Hagan, Grace B Campbell, et al.
JCO Oncology Practice|September 10, 2019
Integrating Family Caregiver Support Into a Gynecologic Oncology Practice: An ASCO Quality Training Program ProjectGrace B Campbell, Michelle M Boisen, Lauren C Hand, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 31, 2016
Surgical Outcomes of Patients Undergoing Extrafascial Hysterectomy After Neoadjuvant Radiotherapy With or Without Chemotherapy for Locally Advanced Endometrial Cancer Clinically Extending to the Cervix or ParametriaMichelle M Boisen, J Austin Vargo, Sushi Beriwal, et al.
Journal of Minimally Invasive Gynecology|May 20, 2022
Same-day Hospital Discharge after Minimally Invasive Hysterectomy in a Gynecologic Oncology Practice: Feasibility, Safety, Predictors of Admission, and Adverse OutcomesAlyssa M Wield, Michael G Cohen, Coralee T Toal, et al.
Pageof 2